The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Abstral 200 microgram sublingual tablets.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 608777302 | 31 July 2021 | 30 Tablets | 24 December 2019 |
Kyowa Kirin Limited is recalling the tablets batch as a precautionary measure, due to the reports of double tablets in a single blister pocket.
This was identified during reference sample inspection and there is a potential low risk of accidental double dosage.
The pharmacists have been adviced to stop supplying the batch immediately and quarantine all remaining stock and return it to their supplier.
